FINWIRES · TerminalLIVE
FINWIRES

Wayfair Adjusted Earnings Miss Views Amid 'Choppy' Start to 2026 for Home Furnishings

作者

-- Wayfair (W) shares tumbled Thursday after the company's first-quarter adjusted earnings fell short of Wall Street's estimates as it navigates a tough macro backdrop amid a "choppy" start to 2026 for the home furnishings category.

The online furniture and home goods retailer's adjusted earnings rose to $0.26 a share for the March quarter from $0.10 a year earlier. Those results missed the Street's views for $0.28. Revenue increased 7.4% to $2.93 billion, exceeding the Street's projections for $2.89 billion.

The home furnishings category saw a "choppy" start to the year amid weather disruptions and higher fuel prices that slowed down consumer spending, Chief Executive Niraj Shah said on an earnings conference call, according to a FactSet transcript.

Wayfair expects the category to have been down in the low-single-digit range for the first quarter. This suggests the company outperformed the market by "a high-single-digit spread," according to Shah.

"This is a cyclical category, which is clearly in a down cycle," Shah told analysts. "While we believe we're due for a mean reversion, the timing remains hard to predict."

Wayfair shares were down nearly 12% in Thursday afternoon trade. The stock has slumped 35% so far this year.

The company saw first-quarter order growth of 3%, compared with a year earlier, Chief Financial Officer Kate Gulliver said on the call. "Within that, we saw a new order of growth of nearly 7% in the quarter, our best result since 2021, and saw our active customer growth finally flip to positive year-over-year after multiple quarters of positive sequential growth."

For the ongoing quarter, Wayfair expects top-line to grow by mid-single digits year over year, Gulliver told analysts.

"We're looking at a category that has been volatile in April so far, trending down in the mid-single-digit range," Gulliver said. "Our share spread has been holding nicely in the high-single-digit range."

Energy prices have surged following the US-Israel war with Iran that has left the crucial Strait of Hormuz effectively closed. The conflict paused following a recent ceasefire between Washington and Tehran, but a framework for a permanent truce is yet to be reached.

"We're continuing to closely watch the broader economic implications and how consumers are managing their wallets as they face higher prices at the gas pump," Shah said on the call.

Price: $66.24, Change: $-7.03, Percent Change: -9.59%

相關文章

Sectors

產業動態:金融

週四下午晚些時候,金融股走高,紐約證券交易所金融指數上漲1.3%,道富金融精選行業SPDR ETF(XLF)上漲0.5%。 費城住房指數上漲1.6%,道富房地產精選產業SPDR ETF(XLRE)上漲1.5%。 比特幣(BTC-USD)上漲0.9%至76,409美元,10年期美國公債殖利率下降2.8個基點至4.39%。 企業新聞方面,根據彭博社報道,AvalonBay Communities(AVB)和Equity Residential(EQR)已就潛在的合併事宜展開磋商,這將是有史以來規模最大的房地產交易之一。 AvalonBay股價下跌1.1%,Equity Residential股價小幅下跌。

$AVB$EQR
Australia

市場傳聞:祖克柏和庫克並未考慮競購西雅圖海鷹隊

根據彭博社週四援引公司和業內消息人士報道,Meta Platforms (META) 首席執行官馬克·扎克伯格和蘋果公司 (AAPL) 首席執行官蒂姆·庫克並未計劃競購美國國家橄欖球聯盟 (NFL) 的西雅圖海鷹隊。 報道稱,Meta 的發言人表示,祖克柏沒有對該球隊進行任何投資或競購,而一位熟悉庫克計畫的人士則否認了他參與此事。 Meta 和蘋果公司均未立即回覆的置評請求。 (市場閒談新聞來自與全球市場專業人士的對話。這些資訊據信來自可靠來源,但可能包含傳聞和猜測。準確性無法保證。)Price: $616.43, Change: $-52.69, Percent Change: -7.87%

$AAPL$META
Australia

Axsome Therapeutics公司稱,FDA已批准Auvality用於治療阿茲海默症躁動症。

Axsome Therapeutics (AXSM) 週四宣布,美國食品藥物管理局 (FDA) 已批准其藥物 Auveality 用於治療阿茲海默症癡呆症相關的躁動症狀。 此核准是基於兩項 3 期臨床試驗,結果顯示,與安慰劑相比,Auveality 能顯著改善躁動症狀,並延長復發時間。 該公司補充說,該藥物作用於大腦中的 N-甲基-D-天冬胺酸 (NMDA) 受體和 σ-1 受體,也獲準用於治療成人重度憂鬱症。 Axsome 的股價在周四的交易中上漲超過 12%。Price: $206.45, Change: $+22.50, Percent Change: +12.23%

$AXSM